Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021
Missing a signal in exercise outcomes–is ventilatory limitation a factor in COPD? Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases Year: 2019
Characterization of COPD patients with severe airflow limitation and high physical activity Source: International Congress 2018 – Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach Year: 2018
How to stage airflow limitation (AL) in patients with stable COPD? Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013
Predictive factors of chronic air flow limitation in the elderly: any gender difference? Source: Eur Respir J 2006; 28: Suppl. 50, 449s Year: 2006
The evaluation of different factors that cause FEV1 decline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001
Atherosclerosis in subjects with COPD is independently determined by the degree of airflow limitation Source: Annual Congress 2012 - The best abstracts in pulmonary rehabilitation Year: 2012
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016
Reversibility of airflow limitation in elderly patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 336s Year: 2007
The repeatability of the negative expired method (NEP) in assessing flow limitation in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 402s Year: 2004
Targeting therapy to the site of airflow limitation in COPD Source: International Congress 2019 – Putting COPD patient needs first: Time for optimizing treatment and device selection Year: 2019
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013
Nasal high flow therapy: The effect on exercise performance in patients with COPD Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018
Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013
The VE/VCO2 slope as a factor associated with the health status in patients with COPD Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation Year: 2012
Relationship of airflow limitation severity with work productivity reduction and sick leave in a Japanese working population Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016
Relationship between symptoms and airflow limitation in COPD: in stable disease and during exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002
LSC - 2020 - The lung DNA methylation profile of patients with COPD: relationship with smoking and airflow limitation severity. Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020
Reproducibility of reversibility in airflow limitation over a year in clinically stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 62s Year: 2005